Product Specifications Manufacturer: Novo Nordisk Active Ingredient: Semaglutide Molecule Class: GLP-1 receptor agonist Concentration: 1 mg per injection Form: Pre-filled injectable pen Administration: Once-weekly subcutaneous injection (abdomen, thigh, or upper arm) Doses per Pen: Typically 4 doses Packaging: 1 pen per box, replacement needles included Clinical reference: Dosage considerations may vary
The decreased expression of genes involved in cholesterol synthesis and bile acid synthesis and the increased expression of genes involved in low-density lipoprotein cholesterol uptake by exendin-4 and liraglutide were mediated by the inhibition of SREBP-2 in palmitic acid (PA)-treated cells
all investigators could not be listed here due to space limitations
Each dollar you pay in copays, deductibles, or coinsurance counts toward this limit
Tirzepatide affects metabolic pathways, gastrointestinal function, and appetite regulation, which means dosing accuracy and product purity are essential to safe use
What should you do if you have questions about the storage and usage of semaglutide